Generic placeholder image

Current Drug Targets - Inflammation & Allergy

Editor-in-Chief

ISSN (Print): 1568-010X
ISSN (Online): 1568-010X

Pathways of T Cell Activation and Terminal Differentiation in Chronic Inflammation

Author(s): Pia Isomaki, Joanna M. Clark, Manvinder Panesar and Andrew P. Cope

Volume 4, Issue 3, 2005

Page: [287 - 293] Pages: 7

DOI: 10.2174/1568010054022042

Price: $65

Abstract

Immune and inflammatory responses are governed by antigen-specific T cells, whose activation, differentiation and effector function are induced by signals delivered via the T cell antigen receptor (TCR) and by costimulatory and cytokine receptors. The molecular events leading to the activation of naïve T cells have been extensively studied and are well characterized. Much less is known about the molecular and biochemical events regulating the activation of T cells in chronic inflammatory diseases such as rheumatoid arthritis (RA). This review examines the current state of knowledge of T cell activation in chronic inflammation, focusing on RA, and summarizes experimental data which indicate that the chronic inflammatory process may profoundly affect TCR and cytokine signal transduction pathways. We present evidence suggesting that in chronic inflammation, the antigen-driven TCR-mediated processes are attenuated, while cytokine-driven effector responses are sustained or even enhanced. The possible implications of this inbalance are discussed.

Keywords: t cell, t cell receptor, signal transduction, inflammation, rheumatoid arthritis, tumor necrosis factor


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy